Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights (Q37982476)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2012

edit

Language	Label	Description	Also known as
English	Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights	scientific article published on March 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

title

Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

author

Keith Flaherty

series ordinal

2

object named as

Keith T Flaherty

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

Reinhard Dummer

series ordinal

1

object named as

Reinhard Dummer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

language of work or name

English

1 reference

based on heuristic

inferred from title

publication date

1 March 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

published in

Current Opinion in Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

page(s)

150-154

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

cites work

A comprehensive catalogue of somatic mutations from a human cancer genome

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE08658

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

DOI

10.1097/CCO.0B013E32834FCA92

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

PubMed publication ID

22316627

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22316627

retrieved

26 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37982476&oldid=2076531502"